Structure-based approaches towards identification of fragments for the low-druggability ATAD2 bromodomain
The transcriptional co-regulator ATAD2 is a prognostic marker for patient survival in many cancers. ATAD2 harbours a bromodomain which may offer an opportunity for pharmacological intervention, but its shallow, polar binding surface makes the development of inhibitors challenging. Here we optimized...
Main Authors: | , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Royal Society of Chemistry
2014
|